IPO News

Get ready for a packed IPO week with 20 new listings! Discover which companies are showing the strongest potential for listing gains, with some aiming for double-digit returns. We break down the key IPOs, their GMPs, and what investors need to watch out for.

Symbiotec Pharmalab's IPO is nearing its August 24th launch, with domestic funds heavily backing its anchor book. Learn what this strong institutional interest means and how Symbiotec's niche market share stacks up against industry peers. We explore the key valuation metrics and potential listing gains investors are watching.

Skyways Air Services' IPO anchor book is filled, with domestic mutual funds and Nomura Singapore leading the charge. The company is set to open its public offering soon. Discover the key investors, potential listing gains, and critical risks to consider before subscribing to this logistics player.

Hy-Tech Engineers' IPO anchor book is packed with domestic funds, led by WhiteOak Capital. With shares priced at a discount to peers, is this a smart entry? We break down the anchor investor sentiment, the company's financials, and what the grey market buzz means for its upcoming debut.

Gemini Edibles & Fats India, makers of 'Freedom Oils', has filed for an IPO. But, it's an Offer for Sale no new money for the company. Find out who is selling shares and how the company is performing against the market.

SEBI has cleared an audiovisual tech firm for its Mainboard IPO. Find out which company received the nod and why another jewellry firm withdrew its offering. Get the key details you need to understand these market movements.

Symbiotec Pharmalab's IPO is now live. Discover what makes this steroid API manufacturer a potential medium to long-term investment. We explore its growth drivers, competitive landscape, and the key factors investors should consider before bidding.

Symbiotec Pharmalab is gearing up for its IPO. Discover its strengths in sterile injectables and key focus areas like respiratory health. We break down what this means for potential investors and compare it to industry peers.

Symbiotec Pharmalab, a manufacturer of steroid-based APIs, is gearing up for an IPO. What does this mean for well-informed investors? Explore the company's strengths, potential challenges, and its place within the competitive pharmaceutical landscape. Discover why parking funds for medium to long-term rewards might be a consideration.